Byron DeLaBarre

3.3k total citations
16 papers, 1.4k citations indexed

About

Byron DeLaBarre is a scholar working on Molecular Biology, Cancer Research and Cell Biology. According to data from OpenAlex, Byron DeLaBarre has authored 16 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 6 papers in Cancer Research and 5 papers in Cell Biology. Recurrent topics in Byron DeLaBarre's work include Cancer, Hypoxia, and Metabolism (5 papers), Endoplasmic Reticulum Stress and Disease (5 papers) and Enzyme Structure and Function (5 papers). Byron DeLaBarre is often cited by papers focused on Cancer, Hypoxia, and Metabolism (5 papers), Endoplasmic Reticulum Stress and Disease (5 papers) and Enzyme Structure and Function (5 papers). Byron DeLaBarre collaborates with scholars based in United States and China. Byron DeLaBarre's co-authors include Axel T. Brünger, John C. Christianson, Ron R. Kopito, William I. Weis, Jonathan Hurov, Andrew P. May, Elizabeth M. Wilson-Kubalek, Isabelle Rouiller, Ronald A. Milligan and Stefan Größ and has published in prestigious journals such as Nature, Journal of Biological Chemistry and Molecular Cell.

In The Last Decade

Byron DeLaBarre

16 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Byron DeLaBarre United States 15 1.1k 571 262 220 193 16 1.4k
Martina Koeva United States 7 1.7k 1.5× 502 0.9× 138 0.5× 105 0.5× 140 0.7× 12 2.0k
Marc L. Mendillo United States 23 2.1k 1.9× 563 1.0× 253 1.0× 160 0.7× 93 0.5× 36 2.6k
Eric S. Witze United States 17 1.4k 1.2× 325 0.6× 168 0.6× 132 0.6× 68 0.4× 25 1.8k
Jimi Wills United Kingdom 17 1.1k 1.0× 423 0.7× 150 0.6× 319 1.4× 70 0.4× 24 1.6k
Bruce A. Posner United States 12 1.5k 1.4× 327 0.6× 160 0.6× 112 0.5× 103 0.5× 19 1.9k
Takafumi Miyamoto Japan 17 1.1k 1.0× 210 0.4× 181 0.7× 136 0.6× 58 0.3× 44 1.5k
Jong W. Yu United States 14 1.3k 1.2× 756 1.3× 127 0.5× 216 1.0× 34 0.2× 15 1.8k
Roland Baumgartner Germany 17 896 0.8× 388 0.7× 197 0.8× 97 0.4× 68 0.4× 27 1.2k
Ingrid Dreveny United Kingdom 24 1.2k 1.0× 424 0.7× 43 0.2× 161 0.7× 140 0.7× 38 1.5k
Rajat Gupta Denmark 14 1.8k 1.6× 412 0.7× 120 0.5× 192 0.9× 58 0.3× 15 2.2k

Countries citing papers authored by Byron DeLaBarre

Since Specialization
Citations

This map shows the geographic impact of Byron DeLaBarre's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Byron DeLaBarre with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Byron DeLaBarre more than expected).

Fields of papers citing papers by Byron DeLaBarre

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Byron DeLaBarre. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Byron DeLaBarre. The network helps show where Byron DeLaBarre may publish in the future.

Co-authorship network of co-authors of Byron DeLaBarre

This figure shows the co-authorship network connecting the top 25 collaborators of Byron DeLaBarre. A scholar is included among the top collaborators of Byron DeLaBarre based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Byron DeLaBarre. Byron DeLaBarre is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
2.
Jia, Wei, Silvana Leit, Jun Kuai, et al.. (2019). An allosteric mechanism for potent inhibition of human ATP-citrate lyase. Nature. 568(7753). 566–570. 122 indexed citations
3.
Davis, Mindy I., Stefan Größ, Min Shen, et al.. (2014). Biochemical, Cellular, and Biophysical Characterization of a Potent Inhibitor of Mutant Isocitrate Dehydrogenase IDH1. Journal of Biological Chemistry. 289(20). 13717–13725. 72 indexed citations
4.
Ulanet, Danielle, Abhishek Jha, Sung Choe, et al.. (2014). Mesenchymal Phenotype Predisposes Lung Cancer Cells to Impaired Proliferation and Redox Stress in Response to Glutaminase Inhibition. PLoS ONE. 9(12). e115144–e115144. 39 indexed citations
5.
DeLaBarre, Byron, Jonathan Hurov, Giovanni Cianchetta, Stuart Murray, & Lenny Dang. (2014). Action at a Distance: Allostery and the Development of Drugs to Target Cancer Cell Metabolism. Chemistry & Biology. 21(9). 1143–1161. 34 indexed citations
6.
Ulanet, Danielle, Abhishek Jha, Sung Choe, et al.. (2014). Mesenchymal phenotype predisposes lung cancer cells to impaired proliferation and redox stress in response to glutaminase inhibition. Cancer & Metabolism. 2(S1). 21 indexed citations
7.
DeLaBarre, Byron, Stefan Größ, Cheng Fang, et al.. (2011). Full-Length Human Glutaminase in Complex with an Allosteric Inhibitor. Biochemistry. 50(50). 10764–10770. 123 indexed citations
8.
Brünger, Axel T., Byron DeLaBarre, Jason M. Davies, & William I. Weis. (2009). X-ray structure determination at low resolution. Acta Crystallographica Section D Biological Crystallography. 65(2). 128–133. 45 indexed citations
9.
10.
DeLaBarre, Byron, John C. Christianson, Ron R. Kopito, & Axel T. Brünger. (2006). Central Pore Residues Mediate the p97/VCP Activity Required for ERAD. Molecular Cell. 22(4). 451–462. 178 indexed citations
11.
DeLaBarre, Byron & Axel T. Brünger. (2006). Considerations for the refinement of low-resolution crystal structures. Acta Crystallographica Section D Biological Crystallography. 62(8). 923–932. 61 indexed citations
12.
DeLaBarre, Byron & Axel T. Brünger. (2005). Nucleotide Dependent Motion and Mechanism of Action of p97/VCP. Journal of Molecular Biology. 347(2). 437–452. 137 indexed citations
13.
Brill, Laurence M., et al.. (2004). Dimerization of Recombinant Tobacco Mosaic Virus Movement Protein. Journal of Virology. 78(7). 3372–3377. 24 indexed citations
14.
DeLaBarre, Byron & Axel T. Brünger. (2003). Complete structure of p97/valosin-containing protein reveals communication between nucleotide domains. Nature Structural & Molecular Biology. 10(10). 856–863. 323 indexed citations
15.
Brünger, Axel T. & Byron DeLaBarre. (2003). NSF and p97/VCP: similar at first, different at last. FEBS Letters. 555(1). 126–133. 67 indexed citations
16.
Rouiller, Isabelle, Byron DeLaBarre, Andrew P. May, et al.. (2002). Conformational changes of the multifunction p97 AAA ATPase during its ATPase cycle. Nature Structural Biology. 9(12). 950–957. 173 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Martina Koeva Breakdown of academic impact, for papers by Marc L. Mendillo Breakdown of academic impact, for papers by Eric S. Witze Breakdown of academic impact, for papers by Jimi Wills Breakdown of academic impact, for papers by Bruce A. Posner Breakdown of academic impact, for papers by Takafumi Miyamoto Breakdown of academic impact, for papers by Jong W. Yu Breakdown of academic impact, for papers by Roland Baumgartner Breakdown of academic impact, for papers by Ingrid Dreveny Breakdown of academic impact, for papers by Rajat Gupta
Rankless by CCL
2026